Yung H. Chyung is Chief Medical Officer of Keros Therapeutics, Inc.. Currently has a direct ownership of 44,000 shares of KROS, which is worth approximately $484,880. The most recent transaction as insider was on Feb 18, 2025, when has been sold 44,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44K
n/a 3M change
n/a 12M change
Total Value Held $484,880

YUNG H. CHYUNG Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2025
BUY
Grant, award, or other acquisition
-
44,000 Added 50.0%
44,000 Common Stock

Also insider at

SRRK
Scholar Rock Holding Corp Healthcare
TALS
Talaris Therapeutics, Inc. Healthcare
YHC

Yung H. Chyung

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Track Activities on KROS